An overview of the use of risk analysis methodologies in radiotherapy facilities in Brazil

Luciana Alves Bezerra; Flávia Cristina Da Silva Teixeira; Eduardo De Paiva

doi:10.15392/2319-0612.2026.3026

Autores/as

Luciana Alves Bezerra Instituto de Radioproteção e Dosimetria
Flávia Cristina Da Silva Teixeira Nuclear Engineering Institute
Eduardo De Paiva Divisão de Física Médica, Instituto de Radioproteção e Dosimetria - IRD/CNEN , Nuclear Engineering Institute

DOI:

https://doi.org/10.15392/2319-0612.2026.3026

Palabras clave:

radiotherapy, patient protection, risk analysis methodologies, SEVRRA, FMEA

Resumen

The increasing incidence of cancer and rapid advancements in radiotherapy technology have significantly heightened the complexity of treatment processes, necessitating robust infrastructure and safety protocols. This study assessed the implementation of risk analysis methodologies in Brazilian radiotherapy facilities through a nationwide survey of 196 centers, with 111 responses (57%). Results show that the Radiotherapy Risk Assessment System (SEVRRA) is the predominant tool, applied in 86.5% of facilities, while Failure Mode and Effects Analysis (FMEA) remains limited (7.2%), with only a small fraction using both. Adoption has been uneven across regions, with the South and Southeast concentrating the majority of facilities, technological resources, and advanced treatment techniques such as IMRT, VMAT, and SRS, while the North and Central-West report fewer centers and less diversity in methodologies. The peak in implementation occurred between 2017 and 2021, particularly in 2019, influenced by regulatory standards and international recommendations. Medical physicists (69.4%) and Radiation Protection Supervisors (27.9%) are the primary professionals responsible for applying risk analysis, though regulatory compliance issues persist. Despite barriers such as workload constraints and limited training, the integration of risk analysis practices has strengthened safety protocols and quality management, underscoring their importance in minimizing risks and safeguarding patient well-being throughout radiotherapy treatment in Brazil.

Descargas

Los datos de descarga aún no están disponibles.

Referencias

[1] PODGORSAK, E. B. Radiation Oncology Physics: A Handbook for Teachers and Students. Vienna, IAEA, 2005.

[2] MIWA, K. Advances in targeted cancer treatment: The role of precision radiation therapy. Journal of Nuclear Medicine & Radiation Therapy, v. 15, p. 06, 2024.

[3] HUQ, M. S. et al. The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management. Medical Physics, v. 43, n. 7, p. 4209-4262, 2016. DOI: https://doi.org/10.1118/1.4947547

[4] LOHMANN, D.; LANG-WELZENBAC, M.; FELDBERGER, L.; SOMMER, E.; BÜCKEN, S.; LOTTER, M.; OTT, O. J.; FIETKAU, R.; BERT, C. Risk analysis for radiotherapy at the Universitätsklinikum Erlangen. Zeitschrift für Medizinische Physik, v. 32, n. 3, p. 273-282, 2022. DOI: https://doi.org/10.1016/j.zemedi.2021.11.002

[5] LOHMANN, D.; SHARIFF, M.; SCHUBERT, P.; SAUER, T. O.; FIETKAU, R.; BERT, C. Unified risk analysis in radiation therapy. Zeitschrift für Medizinische Physik, v. 33, n. 4, p. 479-488, 2023. DOI: https://doi.org/10.1016/j.zemedi.2022.08.006

[6] World Health Organization. Radiotherapy risk profile. Available at: https://cdn.who.int/media/docs/default-source/patient-safety/radiotherapy/090715-who-radiotherapy_risk_profile.pdf?sfvrsn=ec752b08_3. Accessed on: March 15, 2024.

[7] Ibero-American Forum of Radiological and Nuclear Regulatory Agencies. SEVRRA. Available at: http://foroiberam.org/sevrra. Accessed on: March 5, 2023.

[8] KAPLAN, S.; GARRICK, B. J. (1981). On the quantitative definition of risk.

Risk Analysis, v. 1, n 1, 11–27, 1981. DOI: https://doi.org/10.1111/j.1539-6924.1981.tb01350.x

[9] STAMATIS, D. H. Failure Mode and Effect Analysis: FMEA from Theory to Execution. Quality Press, 2003.

[10] PAULSEN, M. Root cause analysis. JAMA, v. 325, n. 3, 225-226, 2021. DOI: https://doi.org/10.1001/jama.2020.24911

[11] SÖLKNER, Lukas et al. Enhancing clinical safety in radiation oncology: A data-driven approach to risk management. Zeitschrift für Medizinische Physik, (accepted, article in press, 2025). DOI: https://doi.org/10.1016/j.zemedi.2025.02.003

[12] JIN, Fu et al. Cancer risk assessment in modern radiotherapy workflow with medical big data. Cancer Management and Research, v. 10, p. 1665-1675, 2018. DOI: https://doi.org/10.2147/CMAR.S164980

[13] LÓPEZ, P. O. et al. A report of preventing accidental exposures from new external beam radiation therapy technologies. Annals of the ICRP, v. 39, n. 4, p. 1-86, 2009. DOI: https://doi.org/10.1016/j.icrp.2009.12.001

[14] VILARAGUT, J. J. et al. Prevention of accidental exposure in radiotherapy: The risk matrix approach. Health Physics, v. 104, n. 2, p. 139-150, 2013. DOI: https://doi.org/10.1097/HP.0b013e3182680379

[15] Comissão Nacional de Energia Nuclear. Diretrizes básicas de proteção radiológica. CNEN NN 3.01. Available at: https://www.gov.br/cnen/pt-br/acesso-rapido/normas/grupo-3/grupo3-nrm301.pdf. Accessed on: January 6, 2024.

[16] Comissão Nacional de Energia Nuclear. Serviços de radioproteção. CNEN NN 3.02. Available at: https://www.gov.br/cnen/pt-br/acesso-rapido/normas/grupo-3/grupo3-nrm302.pdf. Accessed on: May 22, 2023.

[17] Comissão Nacional de Energia Nuclear. Requisitos de segurança e proteção radiológica para serviços de radioterapia. CNEN NN 6.10. Available at: https://www.gov.br/cnen/pt-br/acesso-rapido/normas/grupo-6/grupo6-nrm610.pdf. Accessed on: July 20, 2023.

[18] Comissão Nacional de Energia Nuclear. Certificação da qualificação de supervisores de proteção radiológica. CNEN NN 7.01. Available at: https://www.gov.br/cnen/pt-br/acesso-rapido/normas/grupo-3/grupo3-nrm701.pdf. Accessed on: November 20, 2023.

[19] International Atomic Energy Agency. Application of the risk matrix method to radiotherapy. IAEA TECDOC 1685, Vienna, 2016.

[20] Comissão Nacional de Energia Nuclear. Available at: https://appasp2019.cnen.gov.br/seguranca/cons-ent-prof/lst-entidades-aut-cert.asp?p_ent=44&d=Radioterapia. Accessed on: Dezember 20, 2023.

[21] SUNG, Hyuna et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, v. 71, n. 3, p. 209-249, 2021. DOI: https://doi.org/10.3322/caac.21660